Narlaprevir

Medical Advocates
Narlaprevir

Main Page

ARV Investigational Drugs

Main New/Noteworthy

Home Page

Last Update: September 22, 2016
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

September 2016

FULL-TEXT PDF FILE
Pharmacokinetics of New HCV NS3 Protease Inhibitor Narlaprevir Following Single Dose Use with or without Ritonavir in patients with liver cirrhosis
Isakov V, Koloda D, Tikhonova N, et al Antimicrob Agents Chemother. 2016 Sep 19.

Journal Abstracts, Papers, and Commentaries

FULL-TEXT PDF FILE
Pharmacokinetics of New HCV NS3 Protease Inhibitor Narlaprevir Following Single Dose Use with or without Ritonavir in patients with liver cirrhosis
Isakov V, Koloda D, Tikhonova N, et al Antimicrob Agents Chemother. 2016 Sep 19.

ARV Investigational Drugs

Main New/Noteworthy

Home Page

Narlaprevir